Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Clinical and Translational Gastroenterology|April 11, 2022
Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative ColitisIsabel Quintanilla, Gerhard Jung, Mireya Jimeno, et al.
Therapeutic Advances in Gastroenterology|February 4, 2022
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL studyCarlos Taxonera, María Pilar Martínez-Montiel, Manuel Barreiro-de-Acosta, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 9, 2019
The Harvey-Bradshaw Index Adapted to a Mobile Application Compared with In-Clinic Assessment: The MediCrohn StudyAna Echarri, Isabel Vera, Virginia Ollero, et al.
European Journal of Gastroenterology & Hepatology|December 9, 2021
Clinical characteristics and prognostic factors for Crohn's disease relapses using natural language processing and machine learning: a pilot studyFernando Gomollón, Javier P Gisbert, Iván Guerra, et al.
JMIR Medical Informatics|February 18, 2022
Evaluation of Natural Language Processing for the Identification of Crohn Disease-Related Variables in Spanish Electronic Health Records: A Validation Study for the PREMONITION-CD ProjectCarmen Montoto, Javier P Gisbert, Iván Guerra, et al.
Revista Espanola De Enfermedades Digestivas|June 27, 2025
Assessing inflammatory bowel disease monitoring procedures in Spain: insights from the IBD-PODCAST studyJosé María Huguet, Elena Gómez Delgado, Saioa Rubio, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 26, 2026
Case Study: Dose-Dependent Internal Jugular Vein Response to Lower Body Negative Pressure in Microgravity Quantified by the Flow Directionality IndexHuc Pentinat-Llurba, Richard S Whittle, Adrien Robin, et al.
Crohn'S & Colitis 360|February 14, 2023
Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical PracticeMarta Calvo Moya, Yago González Lama, Belén Ruíz Antorán, et al.
Gastroenterologia Y Hepatologia|July 5, 2011
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experienceJosé Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, et al.
Journal of Travel Medicine|January 18, 2022
Causes of fever in returning travelers: a European multicenter prospective cohort studyDaniel Camprubí-Ferrer, Ludovico Cobuccio, Steven Van Den Broucke, et al.
Pageof 10